ALNYLAM PHARMACEUTICALS, INC.
A biopharmaceutical company developing RNA interference (RNAi) therapeutics.
ALNY | US
Overview
Corporate Details
- ISIN(s):
- US72703U1025 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 675 WEST KENDALL STREET, 2142 CAMBRIDGE
- Website:
- https://www.alnylam.com/
- Sector:
- Manufacturing
Description
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company that pioneers and leads the development of RNA interference (RNAi) therapeutics. The company is dedicated to translating the science of RNAi into a new class of innovative medicines. Its core activities encompass the research, development, manufacturing, and commercialization of therapies that utilize RNAi's natural biological process of gene silencing to target the genetic drivers of disease. This approach offers a novel mechanism for treating a range of debilitating conditions, with a focus on delivering transformational medicines to patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ALNYLAM PHARMACEUTICALS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ALNYLAM PHARMACEUTICALS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ALNYLAM PHARMACEUTICALS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
